LOUISVILLE, Ky., Aug. 14 -- University of Louisville issued the following news release:

A network of cell therapy research centers established by a National Institutes of Health (NIH) grant at the University of Louisville is now enrolling patients in its first clinical trial - a Phase II study of a novel adult stem cell treatment for peripheral arterial disease (PAD). The condition occurs when plaque builds up in the arteries and ultimately blocks blood flow to the legs.

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products